AARDVARK THERAPEUTICS INC (AARD) Stock Price, Quote, News and Overview
NASDAQ:AARD - Nasdaq - US0029421007 - Currency: USD
AARD Quote, Performance and Key Statistics
10.13
+0.61 (+6.41%)
The current stock price of AARD is 10.13 USD.
About AARD
Company Profile
Aardvark Therapeutics Inc is a US-based company operating in industry. The company is headquartered in San Diego, California and currently employs 18 full-time employees. The company went IPO on 2025-02-13. Aardvark Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. The firm targets biological pathways associated with alleviating hunger that has the potential to deliver transformative outcomes for patients. The company is focused on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its initial compounds target TAS2Rs expressed in the gut lumen, which normally respond to the nutrients in food and participate in the gut-brain axis. Its wholly owned lead product candidate, ARD-101 (denatonium acetate monohydrate), is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which it has initiated a Phase III clinical trial for hyperphagia associated with Prader-Willi Syndrome (PWS).
Company Info
AARDVARK THERAPEUTICS INC
4370 La Jolla Village Drive, Suite 1050
San Diego CALIFORNIA US
Employees: 18
Company Website: https://aardvarktherapeutics.com/
Phone: 18582257696
AARDVARK THERAPEUTICS INC / AARD FAQ
What is the stock price of AARDVARK THERAPEUTICS INC today?
The current stock price of AARD is 10.13 USD. The price increased by 6.41% in the last trading session.
What is the ticker symbol for AARDVARK THERAPEUTICS INC stock?
The exchange symbol of AARDVARK THERAPEUTICS INC is AARD and it is listed on the Nasdaq exchange.
On which exchange is AARD stock listed?
AARD stock is listed on the Nasdaq exchange.
What is AARDVARK THERAPEUTICS INC worth?
AARDVARK THERAPEUTICS INC (AARD) has a market capitalization of 225.60M USD. This makes AARD a Micro Cap stock.
How many employees does AARDVARK THERAPEUTICS INC have?
AARDVARK THERAPEUTICS INC (AARD) currently has 18 employees.
Should I buy AARDVARK THERAPEUTICS INC (AARD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AARD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AARD, evaluating the profitability, health, valuation and growth aspects
- AARDVARK THERAPEUTICS INC (AARD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AARDVARK THERAPEUTICS INC (AARD) Sales and EPS estimates to see what analysts future expectations are.
- AARDVARK THERAPEUTICS INC (AARD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AARDVARK THERAPEUTICS INC (AARD) Insider and Institutional Ownership to learn about the owners and their transactions.
- AARDVARK THERAPEUTICS INC (AARD) Stock Chart to make your own analysis
- AARDVARK THERAPEUTICS INC (AARD) Latest news and press-releases to stay up to date.
Does AARDVARK THERAPEUTICS INC (AARD) stock pay dividends?
AARD does not pay a dividend.
What is the Price/Earnings (PE) ratio of AARDVARK THERAPEUTICS INC (AARD)?
AARDVARK THERAPEUTICS INC (AARD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.34).
AARD Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AARD.
AARD Financial Highlights
Over the last trailing twelve months AARD reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS increased by 46.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.61% | ||
| ROE | -8.94% | ||
| Debt/Equity | 0 |